Objective To observe the effect of artemisinin thrombolytic therapy in patients with acute ischemic stroke( AIS). Methods 50 patients with AIS admitted from April 2017 to August 2018 were divided into two groups: group A and group B. They were treated with routine therapy and ateplase thrombolysis respectively,and the curative effect was compared between the two groups. Results The total effective rates of group A and B were 96.0% and the difference was significant( P < 0.05). After treatment,the levels of NHISS and modified RANKIN scale in group B were significantly lower than those in group A,and SOD was significantly higher than that in group A( P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups( P > 0.05). Conclusion Atyplase thrombolytic therapy for AIS is effective,safe and reliable,and worthy of promotion.
Journal of China Prescription Drug